Abstract:BACKGROUND: Pregnant women are ubiquitously exposed to per- and polyfluoroalkyl substances (PFAS). Prenatal exposure to PFAS has been associated with lower birth weight but also with excess adiposity and higher weight in childhood. These mixed findings warrant investigation of the relationship between PFAS and dynamic offspring growth.OBJECTIVES: To investigate the association between prenatal PFAS exposure and early-life growth trajectories during the first 2 y.METHODS: Pregnant women (<math><mrow><mi>n</mi><mo>=</mo><mn>3,426</mn></mrow></math>) were recruited from 2013 to 2016 from the Shanghai Birth Cohort (SBC) Study, and their children were followed up from birth to 2 y of age. Seven PFAS congeners were quantified in pregnant women's serum during the first trimester. Our study population was restricted to 1,350 children who had five repeated measurements for at least one anthropometric measure. Four anthropometric measures, including weight, length/height, weight-for-length, and head circumference, were evaluated at birth, 42 d, 6 months, 12 months, and 24 months, and standardized into z-scores using the World Health Organization reference. Trajectories of each measure were classified into five groups using group-based trajectory modeling. Multinomial logistic regression was used to estimate odds ratio (OR) and 95% confidence interval (CI) for trajectory groups according to <math><mrow><msub><mrow><mi>log</mi></mrow><mrow><mn>2</mn></mrow></msub></mrow></math>-transformed PFAS concentrations, and the moderate-stable group was selected as the reference group for all measures.RESULTS: Higher prenatal exposure to PFAS was associated with elevated odds for the low-rising weight-for-age z-score (WAZ) trajectory, and the high-rising length-for-age z-score (LAZ) trajectory. Meanwhile, PFAS levels were associated with decreased odds for the low-rising and high-rising weight-for-length z-score (WLZ) trajectories. In addition, the associations of PFAS with growth trajectory groups differed by sex, where males had greater odds for the low-rising and low-stable WAZ trajectories and for the high-stable and low-rising WLZ trajectories. In contrast, inverse associations were consistently observed with trajectories of the high-stable, low-stable, and low-rising head-circumference-for-age z-score (HCZ) in relation to most individual PFAS congeners. PFAS mixtures analysis further confirmed the above findings.DISCUSSION: Trajectory analysis approach provided insight into the complex associations between PFAS exposure and offspring growth. Future studies are warranted to confirm the present findings with trajectory modeling strategies and understand the clinical significance of these trajectory groups. https://doi.org/10.1289/EHP9875.

Response to Comment on “associations of Prenatal Exposure to Per- and Polyfluoroalkyl Substances with the Neonatal Birth Size and Hormones in the Growth Hormone/Insulin-Like Growth Factor Axis”: What is the Origin of PFHxS Found in the Human Body?

Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Infancy/child Growth Trajectories Through 2 Years

Association of maternal exposure to perfluoroalkyl and polyfluroalkyl substances with infant growth from birth to 12 months: A prospective cohort study

PFOS, PFOA, Estrogen Homeostasis, and Birth Size in Chinese Infants

Association Between Prenatal Exposure to PFAS and Fetal Sex Hormones: Are the Short-Chain PFAS Safer?

In utero exposure to per-/polyfluoroalkyl substances (PFASs): Preeclampsia in pregnancy and low birth weight for neonates

Associations between gestational exposure to perfluoroalkyl substances, fetal growth, and the mediation effect of thyroid hormones

Mediating effect of endocrine hormones on association between per- and polyfluoroalkyl substances exposure and birth size: Findings from sheyang mini birth cohort study

Associations of Per-/Polyfluoroalkyl Substances with Glucocorticoids and Progestogens in Newborns.

Maternal Per- and Poly-Fluoroalkyl Substances Exposure and Child Adiposity Measures: A Birth Cohort Study

Gestational Exposure to Perfluoroalkyl Substances is Associated with Placental DNA Methylation and Birth Size

Prenatal Exposure to Perfluorobutanesulfonic Acid and Childhood Adiposity: A Prospective Birth Cohort Study in Shanghai, China.

Gestational PFAS exposure and newborn size: The modifying effect of cord blood fatty acids

Prenatal Exposure to Chlorinated Polyfluoroalkyl Ether Sulfonic Acids and Perfluoroalkyl Acids: Potential Role of Maternal Determinants and Associations with Birth Outcomes

Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Child Growth Trajectories in the First Two Years

Prenatal Exposure to Perfluoroalkyl and Polyfluoroalkyl Substances and Birth Outcomes: A Longitudinal Cohort with Repeated Measurements.

Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach

Association Between Prenatal Exposure to Perfluoroalkyl Substances and Anogenital Distance in Female Neonates

Associations of Perfluoroalkyl and Polyfluoroalkyl Substances with Gestational Hypertension and Blood Pressure During Pregnancy: A Cohort Study.

Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age

Exposure to Perfluoroalkyl Substances, DNA Methylation, and Fetal Growth in Pregnant Women